Issue 11, 2019, Issue in Progress
From the journal:

RSC Advances

Correction: Praeruptorin B improves diet-induced hyperlipidemia and alleviates insulin resistance via regulating SREBP signaling pathway

Zu-Guo Zheng,a   Chong Lu,a   Pyone Myat Thu,a   Xin Zhang,a   Hui-Jun Li,a   Ping Lia  and  Xiaojun Xu*ab  

* Corresponding authors

a State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China
E-mail: xiaojunxu2000@163.com

b Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, Jiangsu, China

Abstract

Correction for ‘Praeruptorin B improves diet-induced hyperlipidemia and alleviates insulin resistance via regulating SREBP signaling pathway’ by Zu-Guo Zheng et al., RSC Adv., 2018, 8, 354–366.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C9RA90010A
Article type
Correction
Submitted
31 Jan 2019
Accepted
31 Jan 2019
First published
19 Feb 2019
This article is Open Access
Creative Commons BY license

RSC Adv., 2019,9, 6101-6101

Permissions

Request permissions

Correction: Praeruptorin B improves diet-induced hyperlipidemia and alleviates insulin resistance via regulating SREBP signaling pathway

Z. Zheng, C. Lu, P. M. Thu, X. Zhang, H. Li, P. Li and X. Xu, RSC Adv., 2019, 9, 6101 DOI: 10.1039/C9RA90010A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements